On October 31, 2019, the National Medical products Administration (NMPA) published on official website No. 86 of 2019, identifying 154 medical institutions such as Beijing Lu Daopei Hospital as qualified for clinical trials of medicine, and issued "Drug Clinical Trials Certificate of Institutional Qualification.

Academician Lu Daopei was awarded the "Celebrating the 70th Anniversary of the Founding of the People's Republic of China" Commemorative Medal

The 7th Lu Daopei Hematology Summit Forum was successfully held and V Love Charity Dinner was grandly opened

The 7th Lu Daopei Hematology Summit Forum, co-sponsored by Lu Daopei Medical Group ™ and Tsinghua University Medical College, was grandly opened at the Beijing International Convention Center on July 19, 2019. More than 1,200 well-known hematologists and colleagues from China, Europe, America, Asia Pacific and other regions attended the summit.

International Regenerative Medicine Foundation awarded Lu Daopei Medical Group the "Stem Cell and Regenerative Medicine Action Award"

Lu Daopei Medical Group from China won the only international achievement award.

Lu Daopei Medical Group Synarc Lab Zero Rectification Passed CAP Certification

First successful AML patient with CD 123 CAR-T bridge BMT

On December 27, 2018 (+29 days), Mr. Wu, who suffered from acute myeloid leukemia (AML),infusion  CD123-CAR-T cells at Lu Daopei Hospital and was successfully completed remission. Then the patient has been successfully bridged bone marrow transplantation and discharged with complete remission.

Hebei Yanda Lu Daopei Hospital Receives the highest honor"AAA Credit Evaluation" and "Five-Star Hospital"

Hebei Yanda Lu Daopei Hospital achieved best results in the "dual evaluation" activity carried out by the Chinese Association of Non-Public Medical Institutions, and awarded the highest honor"AAA Credit Evaluation" and "Five-Star Hospital" at the annual meeting of the Chinese Association of Non-Public Medical Institutions on January 6, 2019 .